Commentary: Flow cytometry quantification of tumor-infiltrating lymphocytes to predict the survival of patients with diffuse large B-cell lymphoma

Front Immunol. 2024 Apr 18:15:1377221. doi: 10.3389/fimmu.2024.1377221. eCollection 2024.
No abstract available

Keywords: DLBCL; TIL; TIL-B; TME; clinical decision support tool; flow cytometry; prognosis; tumor-infiltrating lymphocytes.

Publication types

  • Research Support, Non-U.S. Gov't
  • Comment

MeSH terms

  • Flow Cytometry* / methods
  • Humans
  • Lymphocytes, Tumor-Infiltrating* / immunology
  • Lymphocytes, Tumor-Infiltrating* / metabolism
  • Lymphoma, Large B-Cell, Diffuse* / immunology
  • Lymphoma, Large B-Cell, Diffuse* / mortality
  • Prognosis

Grants and funding

The author(s) declare that financial support was received for the research, authorship, and/or publication of this article. The article processing cost is supported by the Natural Science Foundation of Shandong Province (ZR2022MH310, ZR2023MH376).